脂質低下のための標的の進化の風景:分子メカニズムから翻訳的影響まで
Christie M Ballantyne1,2, Giuseppe D Norata3
1Department of Medicine, Baylor College of Medicine, One Baylor Plaza, MS BCM285, Houston, TX 77030, USA.
European heart journal
|September 5, 2025
まとめ
新しい脂質低下標的は,LDL-Cを超えた残留心血管リスクに対応します. 新興治療はトリグリセリド,アポリプロテインB,およびリポプロテイン (a) に焦点を当てて,患者のアウトカムを改善しています.
科学分野:
- 心血管医学
- 代謝障害
- 薬理学について
背景:
- 心血管疾患 (CVD) は,世界の主要な健康問題です.
- 異常な血脂値によって特徴づけられる脂質不全症は,CVDの主要な可変リスク因子である.
- 低密度の脂質タンパク質コレステロール (LDL-C) が主要な治療標的である一方で,トリグリセリド,アポリプロテインB (apoB),およびリポプロテインa (Lpa) などの他の脂質タンパク質により残留リスクが持続する.
研究 の 目的:
- 現行および新興の脂質低下療法とその標的をレビューする.
- 残留心血管疾患のリスクを減らすために,LDL-C以外の要因をターゲットにすることの重要性を強調する.
- 脱脂症の管理のための新しい治療戦略について議論する.
主な方法:
- 脂質代謝と治療目標に関する現在の科学文献のレビュー.
- 既存のおよび新しい脂質低下薬の作用機構の分析
- 脂質タンパク質の改変と心血管リスクの減少に関する進行中の研究について議論する.
主要な成果:
- スタチン,ベンペド酸,PCSK9阻害剤,エゼチミブはコレステロールの生合成,吸収,およびLDL受容体の経路を標的とする.
- ANGPTL3 と apoC-III のような新興標的は,トリグリセリドとLDL-Cの減少のための新しい道を提供します.
- CETPの抑制とLp (a) を標的とする戦略は,心臓血管リスクのさらなる軽減のために調査されています.
結論:
- 脂質と脂質たんぱく質を低下させる標的は急速に拡大しています
- 新しい治療法により,耐性脂質不全症や特定の脂質異常症の患者に新しい選択肢が提供されます.
- より広い範囲のリポタンパク質をターゲットにすることは,総合的な心血管リスク管理に不可欠です.
関連する概念動画
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
863
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
863
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:24Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
01:31Lipid-derived Compounds in the Human Body
5.2K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K